Announcements Trials
Browse Landscape

Phase

Phase NA 46Phase 2 2Phase 3 1Phase 2/3 1Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Genitourinary 1

Conditions

Prostatic Neoplasms 2Motor Activity 2Breast Neoplasms 2Vulvar Neoplasms 1Prostate Adenocarcinoma 1Pancreatic Cancer Liver Metastases 1Neoplasms 1Melanoma 1Leukemia, Myeloid, Acute 1Colorectal Neoplasms 1Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8 1

Interventions

Trastuzumab 303Paclitaxel 256Cyclophosphamide 251Docetaxel 238Capecitabine 175Letrozole 163Carboplatin 163Doxorubicin 145Fulvestrant 144Bevacizumab 121Anastrozole 106Tamoxifen 102exemestane 94Vinorelbine 91Epirubicin 90pertuzumab 88Gemcitabine 84Lapatinib 80Albumin-Bound Paclitaxel 74Radiotherapy 71pembrolizumab 70palbociclib 64130-nm albumin-bound paclitaxel 58eribulin 56Cisplatin 55Everolimus 49pyrotinib 44Taxes 44Goserelin 43Neoadjuvant Therapy 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Breast Neoplasms × Methods × Clear all
NCT01621659 2026-05-11

TITAN

University of Alberta

Phase 2 Active not recruiting
80 enrolled
Breast

Breast Neoplasms, Motor Activity

NCT06049355 2025-05-29

EMBRACE: Exercising Together

OHSU Knight Cancer Institute

Phase 2 Recruiting
400 enrolled
BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡